Decrease in serum levels of advanced glycation end-products by short-term lifestyle modification in non-diabetic middle-aged females

Medical Science Monitor

Volumn 15, Issue 6, 2009, Pages

  Yoshikawa, Takahiro ^a   Miyazaki, Aiko ^b   Fujimoto, Shigeo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUSHIMI Pharmaceutical Co Ltd   (Japan)

Author keywords

Advanced glycation end products; Healthy middle aged females; Physical activity and diet

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADIPOCYTOKINE; ADVANCED GLYCATION END PRODUCT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PENTOSIDINE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY FAT; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIETARY INTAKE; FAT INTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; JAPAN; KIDNEY FUNCTION; LIFESTYLE MODIFICATION; NORMAL HUMAN; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; UREMIA; WALKING;

ADIPOSITY; ADULT; AGED; ARGININE; BODY WEIGHT; CASE-CONTROL STUDIES; DIABETES MELLITUS; EXERCISE; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIFE STYLE; LYSINE; MIDDLE AGED; REGRESSION ANALYSIS; TIME FACTORS; WALKING;

EID: 66749092558     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Thorpe SR, Baynes JW: Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging, 1996; 9: 69-77 (Pubitemid 26261743)
2. Baynes JW, Thorpe SR: Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med, 2000; 28: 1708-1716 (Pubitemid 30628657)
3. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature, 2001; 414: 813-820 (Pubitemid 34000785)
4. Sakata N, Imanaga Y, Meng J et al: Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease. Atherosclerosis, 1999; 142: 67-77 (Pubitemid 28551811)
5. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW: Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int, 1999; 55:389-399
6. Ikeda K, Higashi T, Sano H et al: N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry, 1996; 35: 8075-8083 (Pubitemid 26202550)
7. Reddy S, Bichler J, Wells-Knecht KJ et al: N epsilon-(carboxymethyl) lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry, 1995; 34: 10872-10878
8. Sell DR, Monnier VM: Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem, 1989; 264: 21597-21602 (Pubitemid 20028722)
9. Miyata T, Ueda Y, Shinzato T et al: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol, 1996; 7: 1198-1206 (Pubitemid 27468273)
10. Miyata T, Maeda K, Kurokawa K et al: Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial Transplant, 1997; 12: 255-258 (Pubitemid 27090974)
11. Sjögren P, Basta G, de Caterina R et al: Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon- carboxymethyl-lysine in healthy Swedish men. Atherosclerosis, 2007; 195: e168-75 (Pubitemid 350087983)
12. Maza MP, Bravo A, Leiva L et al: Fluorescent serum and urinary advanced glycoxidation end-products in non- diabetic subjects. Biol Res, 2007; 40: 203-212 (Pubitemid 350111026)
13. Sebekova K, Somoza V, Jarcuskova M et al: Plasma advanced glycation end products are decreased in obese children compared with lean controls. Int J Pediatr Obes, 2008; 21: 1-7 (Epub ahead of print)
14. Koschinsky T, He CJ, Mitsuhashi T et al: Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA, 1997; 94: 6474-6479 (Pubitemid 27270709)
15. Lin RY, Reis ED, Dore AT et al: Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice. Atherosclerosis, 2002; 163: 303-311 (Pubitemid 34615821)
16. Hofmann SM, Dong HJ, Li Z et al: Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes, 2002; 51: 2082-2089 (Pubitemid 34729011)
17. Vlassara H, Cai W, Crandall J et al: Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA, 2002; 99: 15596-15601 (Pubitemid 35403978)
18. Hellénius ML, de Faire U, Berglund B et al: Diet and exercise are equally effective in reducing risk for cardiovascular disease. Results of a randomized controlled study in men with slightly to moderately raised cardiovascular risk factors. Atherosclerosis, 1993; 103: 81-91
19. th ed. Tokyo, Japan National Printing Bureau, 2000
20. Hara T, Fujiwara H, Nakao H et al: Body composition is related to increase in plasma adiponectin levels rather than training in young obese men. Eur J Appl Physiol, 2005; 94: 520-526 (Pubitemid 41136051)
21. Matthews DR, Hosker JP, Rudenski AS et al: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28: 412-419 (Pubitemid 15018832)
22. Takeuchi M, Makita Z, Yanagisawa K et al: Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients. Mol Med, 1999; 5: 393-405 (Pubitemid 29382313)
23. Sanaka T, Funaki T, Tanaka T et al: Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure. Nephron, 2002; 91: 64-73 (Pubitemid 34522834)
24. Nakayama K, Terawaki H, Nakayama M et al: Reduction of serum antioxidative capacity during hemodialysis. Clin Exp Nephrol, 2007; 11: 218-224 (Pubitemid 47476795)
25. Verde V, Fogliano V, Ritieni A et al: Use of N,N-dimethyl-p- phenylenediamine to evaluate the oxidative status of human plasma. Free Radic Res, 2002; 36: 869-873 (Pubitemid 34830820)
26. Kume S, Takeya M, Mori T et al: Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol, 1995; 147: 654-667
27. Sakata N, Imanaga Y, Meng J et al: Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions. Atherosclerosis, 1998; 141: 61-75 (Pubitemid 28539417)
28. Makino H, Shikata K, Hironaka K et al: Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int, 1995; 48: 517-526
29. Sugimoto K, Nishizawa Y, Horiuchi S, Yagihashi S: Localization in human diabetic peripheral nerve of N(epsilon)-carboxymethyllysine-protein adducts, an advanced glycation endproduct. Diabetologia, 1997; 40: 1380-1387 (Pubitemid 28004930)
30. Yamada K, Miyahara Y, Hamaguchi K et al: Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure. Clin Nephrol, 1994; 42: 354-361
31. Odetti P, Rossi S, Monacelli F et al: Advanced glycation end products and bone loss during aging. Ann NY Acad Sci, 2005; 1043: 710-717 (Pubitemid 41123964)
32. Morbini P, Villa C, Campo I et al: The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol, 2006; 19: 1437-1445
33. Monnier VM, Sell DR, Genuth S: Glycation products as markers and predictors of the progression of diabetic complications. Ann NY Acad Sci, 2005; 1043: 567-581 (Pubitemid 41123947)
34. Smit AJ, Hartog JW, Voors AA, van Veldhuisen DJ: Advanced glycation endproducts in chronic heart failure. Ann NY Acad Sci, 2008; 1126: 225-230
35. Sugiyama S, Miyata T, Ueda Y et al: Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J Am Soc Nephrol, 1998; 9: 1681-1688 (Pubitemid 28405076)
36. Kitauchi T, Yoshida K, Yoneda T et al: Association between pentosidine and arteriosclerosis in patients receiving hemodialysis. Clin Exp Nephrol, 2004; 8: 48-53 (Pubitemid 38508655)
37. Nofer JR, Kehrel B, Fobker M et al: HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis, 2002; 161: 1-16 (Pubitemid 34214816)
38. Sviridov D, Nestel P: Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis, 2002; 161: 245-254 (Pubitemid 34219176)
39. Oram JF: Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1. Trends Mol Med, 2002; 8: 168-173 (Pubitemid 34302905)
40. Zhao Y, Marcel YL: Serum albumin is a significant intermediate in cholesterol transfer between cells and lipoproteins. Biochemistry, 1996; 35: 7174-7180 (Pubitemid 26182109)
41. Ho YK, Brown MS, Goldstein JL: Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents. J Lipid Res, 1980; 21: 391-398 (Pubitemid 11235475)
42. Machado AP, Pinto RS, Moysés ZP et al: Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products. Int J Biochem Cell Biol, 2006; 38: 392-403 (Pubitemid 41821886)
43. Goldberg T, Cai W, Peppa M et al: Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc, 2004; 104: 1287-1291 (Pubitemid 39036519)
44. Uribarri J, Peppa M, Cai W et al: Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am J Kidney Dis, 2003; 42: 532-538 (Pubitemid 37048129)
45. Schiel R, Franke S, Appel T et al: Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN). J Diabetes Complications, 2003; 17: 90-97 (Pubitemid 36279506)
46. Lyons TJ, Bailie KE, Dyer DG et al: Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. J Clin Invest, 1991; 87: 1910-1915
47. Bianchi C, Penno G, Daniele G et al: Optimizing management of metabolic syndrome to reduce risk: focus on life-style. Intern Emerg Med, 2008; 3: 87-98
48. Sgarbieri VC, Amaya J, Tanaka M, Chichester CO: Nutritional consequences of the Maillard reaction. Amino acid availability from fructoseleucine and fructose-tryptophan in the rat. J Nutr, 1973; 103: 657-663
49. Finot PA, Magnenat E: Metabolic transit of early and advanced Maillard products. Prog Food Nutr Sci, 1981; 5: 193-207
50. Uribarri J, Cai W, Sandu O et al: Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann NY Acad Sci, 2005; 1043: 461-466 (Pubitemid 41123934)
51. Rashid S, Genest J: Effect of obesity on high-density lipoprotein metabolism. Obesity (Silver Spring), 2007; 15: 2875-2888
52. Leon AS, Sanchez OA: Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc, 2001; 33(6 Suppl.): S502-15 (Pubitemid 32524744)
53. Wood PD, Stefanick ML, Dreon DM et al: Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med, 1988; 319: 1173-1179 (Pubitemid 18259141)
54. Leon AS, Conrad J, Hunninghake DB, Serfass R: Effects of a vigorous walking program on body composition, and carbohydrate and lipid metabolism of obese young men. Am J Clin Nutr, 1979; 32: 1776-1787 (Pubitemid 10220285)
55. Lewis S, Haskell WL, Wood PD et al: Effects of physical activity on weight reduction in obese middle-aged women. Am J Clin Nutr, 1976; 29: 151-156
56. Gerhard GT, Connor SL, Wander RC, Connor WE: Plasma lipid and lipoprotein responsiveness to dietary fat and cholesterol in premenopausal African American and white women. Am J Clin Nutr, 2000; 72: 56-63 (Pubitemid 30441657)